✦ LIBER ✦

Analysis of CLLU1 expression levels before and after therapy in patients with chronic lymphocytic leukemia

✍ Scribed by Anne Mette Buhl; Danelle F. James; Donna Neuberg; Sonia Jain; Laura Z. Rassenti; Thomas J. Kipps

Book ID: 114794911
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 211 KB
Volume: 86
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2011.01588.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CLLU1 expression levels predict time to

CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia

✍ Anne Mette Buhl; Jesper Jurlander; Christian Hartmann Geisler; Lone Bredo Peders 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

The CLLU1 expression level is a stable a

The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone

✍ Buhl, A M; Novotny, G W; Josefsson, P; Nielsen, J E; Pedersen, L B; Geisler, C; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 227 KB

Prognostic value of plasma interleukin-6

Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia

✍ Raymond Lai; Susan O'Brien; Taghi Maushouri; Anna Rogers; Hagop Kantarjian; Mich 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Background: Interleukin 6 (il-6) is a b-cell growth and differentiation factor, which may promote the growth of b-cell neoplasms. in chronic lymphocytic leukemia (cll) patients, il-6 plasma levels increased in a stage-dependent manner, suggesting that il-6 may be a useful prognostic marker. the

Serum levels of 2′, 5 oligoadenylate syn

Serum levels of 2′, 5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia

✍ Dr. C. Musolino; P. Grosso; A. Alonci; A. Allegra; A. Orlando; M. Cincotta; G. B 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

Modulation of CD20 antigen expression af

Modulation of CD20 antigen expression after rituximab treatment: A retrospective study in patients with chronic lymphocytic leukemia

✍ Fiorella D’Auria; Roberto Guariglia; Oreste Villani; Giovanna Mansueto; Vitina G 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 94 KB

PCN70 COST-EFFECTIVENESS ANALYSIS OF RIT

PCN70 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN BRAZIL

✍ CS Chiattone; LG Borges; E Santos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB